AXSM (STOCKS)
Axsome Therapeutics, Inc
$178.330000
+0.220000 (+0.12%)
Prev close: $178.110000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Herriott Tabuteau
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $9,122.17M
- Employees
- 816
- P/E (TTM)
- -48.27
- P/B (TTM)
- 102.64
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
15
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.56 | $-0.68 | +0.1226 | +17.96% |
|
Sep 2025 (Q3)
|
$-0.94 | $-0.88 | -0.0571 | -6.47% |
|
Jun 2025 (Q2)
|
$-0.97 | $-1.12 | +0.1489 | +13.31% |
|
Mar 2025 (Q1)
|
$-1.22 | $-1.35 | +0.1325 | +9.80% |
Financial Statements
| Revenues | $638.50M |
| Benefits Costs and Expenses | $822.20M |
| Costs And Expenses | $805.26M |
| Operating Expenses | $805.26M |
| Selling, General, and Administrative Expenses | $570.60M |
| Research and Development | $183.28M |
| Other Operating Expenses | $51.38M |
| Operating Income/Loss | -$166.76M |
| Income/Loss From Continuing Operations After Tax | -$183.17M |
| Income/Loss From Continuing Operations Before Tax | -$183.70M |
| Income Tax Expense/Benefit | -$530.00K |
| Interest Expense, Operating | -$15.93M |
| Net Income/Loss | -$183.17M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$183.17M |
| Net Income/Loss Available To Common Stockholders, Basic | -$183.17M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.68 |
| Diluted Earnings Per Share | -$3.68 |
| Basic Average Shares | 49,747,178 |
| Diluted Average Shares | 49,747,178 |
| Assets | $689.81M |
| Current Assets | $588.99M |
| Inventory | $27.94M |
| Other Current Assets | $561.05M |
| Noncurrent Assets | $100.82M |
| Fixed Assets | $562.00K |
| Intangible Assets | $40.52M |
| Other Non-current Assets | $59.74M |
| Liabilities | $601.51M |
| Current Liabilities | $378.84M |
| Accounts Payable | $65.54M |
| Wages | $36.94M |
| Other Current Liabilities | $276.36M |
| Noncurrent Liabilities | $222.67M |
| Equity | $88.30M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $88.30M |
| Liabilities And Equity | $689.81M |
| Net Cash Flow From Operating Activities | -$93.41M |
| Net Cash Flow From Operating Activities, Continuing | -$93.41M |
| Net Cash Flow From Investing Activities | -$480.00K |
| Net Cash Flow From Investing Activities, Continuing | -$480.00K |
| Net Cash Flow From Financing Activities | $101.47M |
| Net Cash Flow From Financing Activities, Continuing | $101.47M |
| Net Cash Flow | $7.58M |
| Net Cash Flow, Continuing | $7.58M |
| Comprehensive Income/Loss | -$183.17M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$183.17M |
| Other Comprehensive Income/Loss | $0.00 |